GlassScriptPhysician profile
Nitin N Patel
NPI 1831327675
$3,726.88
in general payments reported to CMS, 2019-2025
37 companies · $2,021 in 2025
The $2,021 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.71 · 2020: $83.42 · 2021: $56.18 · 2022: $600 · 2023: $427 · 2024: $511 · 2025: $2,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,624 · Travel and Lodging: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,623.56 |
| Travel and Lodging | $336.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,170.29 | 2023-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $559.15 | 2022-2025 | Interstim |
| Boston Scientific Corporation | $203.31 | 2020-2025 | Lithovue |
| Procept Biorobotics Corporation | $179.99 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $168.50 | 2022-2024 | |
| 180 Medical, INC. | $143.74 | 2022-2025 | |
| Urogen Pharma, INC. | $129.18 | 2023-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $104.22 | 2024-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $97.85 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $94.37 | 2021-2023 | Lynparza, Keytruda, Welireg |
| Accord Healthcare, INC. | $71.99 | 2022-2023 | |
| Astellas Pharma US INC | $71.84 | 2019-2024 | Veozah |
| Laborie Medical Technologies Corp. | $66.76 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $62.06 | 2023-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $61.80 | 2022-2023 | Xiaflex |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $47.92 | 2025 | |
| Abc Home Medical Supply, INC. | $42.75 | 2025 | |
| Olympus America INC. | $41.78 | 2024-2025 | Itind System, Hd Camera Head |
| Myovant Sciences INC. | $41.43 | 2021-2022 | |
| Endo USA, INC. | $35.29 | 2025 | Xiaflex, Aveed |
| Teleflex LLC | $33.98 | 2024-2025 | Urolift, Barrigel |
| Axonics, INC. | $32.69 | 2022-2024 | Axonics |
| Civco Medical Instruments | $27.36 | 2025 | |
| Mimedx Group, INC. | $24.41 | 2025 | |
| Corcept Therapeutics | $22.97 | 2023 | Korlym |
| Dendreon Pharmaceuticals LLC | $19.15 | 2024 | Provenge |
| Abbott Laboratories | $19.05 | 2025 | Freestyle Libre 3 |
| Ferring Pharmaceuticals INC. | $18.04 | 2024 | Adstiladrin |
| Calyxo, INC. | $17.82 | 2025 | Cvac Aspiration System |
| Amgen INC. | $17.33 | 2022 | |
| Hollister Incorporated | $16.45 | 2022 | |
| Urovant Sciences INC | $14.98 | 2022 | |
| Janssen Biotech, INC. | $14.24 | 2022 | |
| Immunitybio, INC. | $14.24 | 2024 | |
| Palette Life Sciences, INC. | $14.19 | 2022 | |
| Lilly USA, LLC | $12.90 | 2019 | |
| Photocure INC | $12.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.